SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-13-043482
Filing Date
2013-02-07
Accepted
2013-02-07 16:16:04
Documents
5
Period of Report
2013-02-07
Items
Item 2.02: Results of Operations and Financial Condition
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d481952d8k.htm 8-K 17587
2 EARNINGS PRESS RELEASE d481952dex991.htm EX-99.1 70707
3 PRESS RELEASE d481952dex992.htm EX-99.2 11088
4 GRAPHIC g481952image001.jpg GRAPHIC 11479
5 GRAPHIC g481952image002.jpg GRAPHIC 11479
  Complete submission text file 0001193125-13-043482.txt   132686
Mailing Address 20 ENTERPRISE SUITE 200 ALISO VIEJO CA 92656
Business Address 20 ENTERPRISE SUITE 200 ALISO VIEJO CA 92656 949-389-6700
AVANIR PHARMACEUTICALS, INC. (Filer) CIK: 0000858803 (see all company filings)

IRS No.: 330314804 | State of Incorp.: DE | Fiscal Year End: 0930
Type: 8-K | Act: 34 | File No.: 001-15803 | Film No.: 13582646
SIC: 2834 Pharmaceutical Preparations